Common Contracts

EX-99.1 2 d629664dex991.htm EX-99.1 TENTH AMENDMENT TO FACILITY AGREEMENT

Facility Agreement • May 5th, 2020 • New York

• Contract Type
  Facility Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This TENTH AMENDMENT TO FACILITY AGREEMENT (this “Amendment”) dated as of September 26, 2018, is by and among MannKind Corporation, a Delaware corporation (the “Borrower”), MannKind LLC, a Delaware limited liability company (the “Guarantor,” and together with the Borrower collectively, the “Obligors”), Deerfield Private Design Fund II, L.P. (“DPDF”) and Deerfield Private Design International II, L.P. (“DPDI” and, together with DPDF, the “Purchasers”). Capitalized terms used herein which are defined in the Facility Agreement (as defined below), unless otherwise defined herein, shall have the meanings ascribed to them in the Facility Agreement.

TENTH AMENDMENT TO FACILITY AGREEMENT

Facility Agreement • September 27th, 2018 • Mannkind Corp • Pharmaceutical preparations • New York

• Contract Type
  Facility Agreement
• Filed
  September 27th, 2018
• Company
  Mannkind Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This TENTH AMENDMENT TO FACILITY AGREEMENT (this “Amendment”) dated as of September 26, 2018, is by and among MannKind Corporation, a Delaware corporation (the “Borrower”), MannKind LLC, a Delaware limited liability company (the “Guarantor,” and together with the Borrower collectively, the “Obligors”), Deerfield Private Design Fund II, L.P. (“DPDF”) and Deerfield Private Design International II, L.P. (“DPDI” and, together with DPDF, the “Purchasers”). Capitalized terms used herein which are defined in the Facility Agreement (as defined below), unless otherwise defined herein, shall have the meanings ascribed to them in the Facility Agreement.

NINTH AMENDMENT TO FACILITY AGREEMENT

Facility Agreement • September 5th, 2018 • Mannkind Corp • Pharmaceutical preparations • New York

• Contract Type
  Facility Agreement
• Filed
  September 5th, 2018
• Company
  Mannkind Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This NINTH AMENDMENT TO FACILITY AGREEMENT (this “Amendment”) dated as of September 5, 2018, is by and among MannKind Corporation, a Delaware corporation (the “Borrower”), MannKind LLC, a Delaware limited liability company (the “Guarantor,” and together with the Borrower collectively, the “Obligors”), Deerfield Private Design Fund II, L.P. (“DPDF”) and Deerfield Private Design International II, L.P. (“DPDI” and, together with DPDF, the “Purchasers”). Capitalized terms used herein which are defined in the Facility Agreement (as defined below), unless otherwise defined herein, shall have the meanings ascribed to them in the Facility Agreement.